Zhejiang Medicine Hits Day High with Strong 5.61% Intraday Surge

Zhejiang Medicine Co., Ltd. has experienced a notable increase of 5.61% on March 11, 2026, reaching an intraday high of CNY 17.89. This performance stands out against the backdrop of the China Shanghai Composite, which only saw a modest gain of 0.25% on the same day. Over the past week, Zhejiang Medicine has shown a solid performance with a 4.61% increase, while its one-month performance reflects a significant rise of 10.36%. Year-to-date, the stock has surged by 27.63%, indicating a strong start to the year compared to the broader market's 4.15% gain. Despite these positive short-term trends, the company has faced challenges in long-term growth, with net sales growing at an annual rate of 4.64% over the last five years. However, it has reported positive results for the last four consecutive quarters, showcasing a robust operating cash flow of CNY 2,018.84 million and a healthy cash position of CNY 6,124.58 million. With a market capitalization of CNY 15,352 million, Zhejiang Medicine operates within the Pharmaceuticals & Biotechnology sector, maintaining a price-to-earnings ratio of 10.00 and a dividend yield of 2.31%.